非透析慢性肾脏病患者发生左心室肥厚的危险因素分析

    Risk factors of left ventricular hypertrophy in patients with non-dialysis chronic kidney disease

    • 摘要: 目的 探讨和分析非透析慢性肾脏病(ND-CKD)患者发生左心室肥厚(LVH)的危险因素,为预防ND-CKD患者LVH的发生提供依据。方法 收集2016年1月至2018年5月就诊于山西医科大学第二医院的1 001例ND-CKD患者的临床资料,按照LVH发生情况分为LVH组(195例)与非LVH组(806例),比较两组患者的临床资料,采用Logistic回归分析研究ND-CKD患者发生LVH的危险因素,采用ROC曲线研究ND-CKD患者发生LVH的预测指标。结果 Logistic回归分析结果显示收缩压(OR=1.012)、β2-微球蛋白(OR=0.939)、总胆固醇(OR=1.183)、同型半胱氨酸(OR=1.023)、B型钠尿肽(OR=1.001)及红细胞沉降率(OR=1.010)是ND-CKD患者发生LVH的独立危险因素。ROC曲线分析结果显示BNP为预测ND-CKD患者发生LVH的较好的指标。结论 对于LVH发生的危险因素给予早期临床干预,可能会减少或延缓LVH的发生,并且改善CKD患者的预后。

       

      Abstract: Objective To explore and analyze the risk factors of left ventricular hypertrophy (LVH) in patients with non-dialysis chronic kidney disease (ND-CKD), and to provide evidence for prevention of LVH in patients with ND-CKD. Methods The clinical data of 1001 ND-CKD patients who were admitted to the Second Hospital of Shanxi Medical University from January to May 2018 were collected. According to the occurrence of LVH, the patients were divided into LVH group (195 cases) and non-LVH group (806 cases). The clinical data of the two groups were compared. Logistic regression analysis was used to study the risk factors of LVH in ND-CKD patients. The ROC curve was used to study the predictive index of LVH in ND-CKD patients. Results Logistic regression analysis showed systolic blood pressure (OR=1.012), β2-microglobulin (OR=0.939), total cholesterol (OR=1.183), homocysteine (OR=1.023), B-type natriuretic peptide (BNP) (OR=1.001) and erythrocyte sedimentation rate (OR=1.010) were independent risk factors of LVH in patients with ND-CKD. ROC curve analysis showed that BNP was good indicator for predicting LVH in patients with ND-CKD. Conclusions Early clinical intervention for risk factors of LVH may reduce or delay the onset of LVH and improve the prognosis of patients with CKD.

       

    /

    返回文章
    返回